Pneumocystis jirovecii pneumonia in patientswith hematological diseases after hematopoietic stem cell transplantation and chemotherapy

被引：0
|
作者：
Rogacheva, Y. A. [1 ]
Popova, M. O. [1 ]
Volkova, A. G. [1 ]
Ekushev, K. A. [1 ]
Pirogova, O. V. [1 ]
Pinegina, O. N. [1 ]
Ignatieva, S. M. [2 ]
Bogomolova, T. S. [2 ]
Paina, O. V. [1 ]
Bykova, T. A. [1 ]
Darskaya, E. I. [1 ]
Vladovskaya, M. D. [1 ]
Smirnov, B. I. [1 ]
Moiseev, I. S. [1 ]
Bondarenko, S. N. [1 ]
Zubarovskaya, L. S. [1 ]
Klimko, N. N. [2 ]
Afanasyev, B. V. [3 ]
机构：
[1] R Gorbacheva Inst Children Oncol Hematol & Transp, St Petersburg, Russia
[2] II Mechnikov North Western State Med Univ, St Petersburg, Russia
[3] I Pavlov First St Petersburg State Med Univ, St Petersburg, Russia
来源：
MEDICAL MYCOLOGY | 2018年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PP5.11
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [41] Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature
    Burzio, Carlo
    Balzani, Eleonora
    Corcione, Silvia
    Montrucchio, Giorgia
    Trompeo, Anna Chiara
    Brazzi, Luca
    PATHOGENS, 2023, 12 (10):
  • [42] Autologous hematopoietic stem cell transplantation for malignant hematological diseases: 100 Cases analysis
    Da, WM
    Zhang, BL
    Zhang, YZ
    Yao, SJ
    Gao, CJ
    Wu, XX
    Han, XP
    BLOOD, 2002, 100 (11) : 481B - 481B
  • [43] Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation
    Ruggeri, Annalisa
    Paviglianiti, Annalisa
    Volt, Fernanda
    Kenzey, Chantal
    Rafii, Hanadi
    Rocha, Vanderson
    Gluckman, Eliane
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (35) : 4535 - 4544
  • [44] Contemporary US Prevalence and Outcomes of Pneumocystis jirovecii Pneumonia and Toxoplasmosis in Pediatric Solid Organ and Hematopoietic Cell Transplantation Recipients.
    Ardura, M. I.
    Stanek, J.
    Hanisch, B.
    Hanisch, B.
    Sprott, K.
    Rangarajan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 416 - 417
  • [45] Pneumocystis jirovecii Pneumonia and Use of mTOR Inhibitors in Kidney Transplantation
    Coussement, Julien
    Manuel, Oriol
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) : 752 - 753
  • [46] Quality of Life of Hematological Neoplasm Survivors After Hematopoietic Stem Cell Transplantation
    Moya-Martinez, Pablo
    Ortega-Ortega, Marta
    Del Pozo-Rubio, Raul
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (08) : 1847 - 1855
  • [47] Risk Factors of Pneumocystis Jirovecii Pneumonia in Patients with Rheumatic Diseases
    Ekren, P. Korkmaz
    Nesil, I.
    Zihni, F. Yargucu
    Guruz, A.
    Toz, S.
    Turgay, N.
    Sayiner, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [48] No Recurrence of Pneumocystis jirovecii Pneumonia after Solid Organ Transplantation Regardless of Secondary Prophylaxis
    Kim, Tark
    Sung, Heungsup
    Lee, Yu-Mi
    Hong, Hyo-Lim
    Kim, Sung-Han
    Choi, Sang-Ho
    Woo, Jun Hee
    Kim, Yang Soo
    Lee, Sang-Oh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 6041 - 6043
  • [49] Reactivation of hepatitis B after hematopoietic stem cell transplantation for hematological malignancy
    Nakamoto, Shingo
    Kanda, Tatsuo
    Wu, Shuang
    Jiang, Xia
    Miyamura, Tatsuo
    Imazeki, Fumio
    Shirasawa, Hiroshi
    Nakaseko, Chiaki
    Yokosuka, Osamu
    HEPATOLOGY, 2013, 58 : 621A - 621A
  • [50] Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation
    Lipsitt, Amanda
    Hijano, Diego R.
    Ferrolino, Jose A.
    Dallas, Ronald
    Sharma, Akshay
    Maron, Gabriela
    PEDIATRIC BLOOD & CANCER, 2024, 71 (10)
12345